Physician risk perceptions and surveillance practices for tyrosine kinase inhibitor long-term effects in pediatric CML.
Saved in:
| Title: | Physician risk perceptions and surveillance practices for tyrosine kinase inhibitor long-term effects in pediatric CML. |
|---|---|
| Authors: | Smith SM; Department of Pediatrics, Division of Hematology, Oncology, Stem Cell Transplant and Regenerative Medicine, Stanford University School of Medicine, Palo Alto, California, USA., Zhang S; Department of Medicine, Quantitative Sciences Unit, Stanford University School of Medicine, Palo Alto, California, USA., Sundaram V; Department of Medicine, Quantitative Sciences Unit, Stanford University School of Medicine, Palo Alto, California, USA., Roth M; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Andolina JR; Department of Pediatrics, Golisano Children's Hospital, University of Rochester Medical Center, Rochester, New York, USA., Schapira L; Department of Medicine, Division of Oncology, Stanford Cancer Institute and Stanford University School of Medicine, Palo Alto, California, USA., Sakamoto KM; Department of Pediatrics, Division of Hematology, Oncology, Stem Cell Transplant and Regenerative Medicine, Stanford University School of Medicine, Palo Alto, California, USA., Kolb EA; Department of Pediatrics, Nemours/Alfred I. duPont Hospital for Children, Nemours Center for Cancer and Blood Disorders, Wilmington, Delaware, USA., Hijiya N; Pediatric Hematology, Oncology, and Stem Cell Transplant, Columbia University Irving Medical Center, New York, New York, USA., Chaudhury S; Department of Pediatrics, Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. |
| Source: | Pediatric hematology and oncology [Pediatr Hematol Oncol] 2022 Aug; Vol. 39 (5), pp. 453-467. Date of Electronic Publication: 2021 Dec 17. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Informa Healthcare Country of Publication: England NLM ID: 8700164 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-0669 (Electronic) Linking ISSN: 08880018 NLM ISO Abbreviation: Pediatr Hematol Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1521-0669 |
|---|---|
| DOI: | 10.1080/08880018.2021.2017085 |
